Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
What Elevance said, and why your clock started January 28, 2026
Direct answer: On the January 28, 2026 Q4 2025 earnings call, Elevance Health CEO Gail Boudreaux told investors the company is using analytics to flag outlier utilization and billing in high-cost substance use disorder settings, then acting on those flags with provider education, claims review changes, and payment accuracy enforcement. If you run a SUD or mental health program contracted with Anthem, Wellpoint, or any Elevance Medicaid plan in Florida, Tennessee, Georgia, or Indiana, treat that statement as your operational warning.
Boudreaux’s exact framing on the call: “In Medicaid, we’re strengthening our analytics to identify outlier utilization and billing patterns in high-cost substance use disorder treatment settings, while maintaining access to clinically appropriate care.” She added that the insights are enabling “targeted actions, including provider education, claims review enhancements, and payment accuracy and compliance initiatives where appropriate, consistent with program requirements and clinical guidelines.” The transcript is public on Motley Fool and referenced in Elevance’s own investor relations materials.
Two things operators should notice. First, the trigger is Medicaid margin pressure. Analyst coverage of the call flagged that Boudreaux described repositioning the book of business, including exiting lower-margin geographies and tightening pricing, to stabilize margins. Second, Elevance leadership specifically named behavioral health as a category where Carelon will run harder in 2026. The cost-recovery target has a name on it. It is you.
The Carelon payment integrity machine is already running
This is not a future-state announcement. Elevance has publicly confirmed that predictive analytics supported by AI is identifying members at risk for health concerns, including substance use disorder, and that AI is embedded in clinical operational workflows and scaled across the organization, according to Healthcare Finance News coverage of the Q1 2026 earnings call.
Operators should expect the same pattern other payers have run for years:
- Pre-payment claim edits on codes Carelon flags as outliers
- Retrospective focused audits with broad date ranges
- Medical-necessity documentation requests tied to ASAM Criteria, 4th Edition placement
- SIU referrals and recoupment demands
- Provider re-education letters that double as audit predicates
The analytics are the trigger. The SIU audit is the response. And the appeal window on a pre-payment edit is short, so the compliance program you have on the day the letter lands is the compliance program you get to defend with.
The federal data tells you exactly where Carelon's models will hunt
If you want to know what Carelon will flag, look at what federal auditors already flag. CMS reported that the FY2024 Medicaid improper payment rate was 5.09%, or $31.10 billion, and 79.11% of those improper payments were the result of insufficient documentation. The FY2025 rate rose to 6.12%, or $37.39 billion, with 77.17% still tied to insufficient documentation. That is the single largest target on a payer’s heat map: services that probably happened but cannot be defended on paper.
The pattern repeats at the state level. In Ohio in December 2025, Auditor of State Keith Faber concluded that Empowered for Excellence Behavioral Health of Ohio was paid $14.9 million for 114,800 substance use disorder, mental health, and professional medical services between January 1, 2021 and December 31, 2023, and recommended repayment of about $1.87 million tied to treatment plans that did not authorize the services billed, missing documentation, and services exceeding daily limitations. One provider. One state. Nearly two million dollars on the table.
HHS-OIG has hit the same vein from the federal side. A February 2026 OIG audit concluded that Colorado made at least $77.8 million in improper fee-for-service Medicaid payments for ABA in 2022 and 2023, with all 100 sampled enrollee-months containing improper or potentially improper claims and a federal refund recommendation of $42.6 million. Prior OIG audits in the same series found Indiana made at least $56 million, Wisconsin at least $18.5 million, and Maine at least $45.6 million in improper Medicaid payments for autism-related services. Same root cause every time: documentation that did not support the claim.
What to fix before the pre-payment edits land
Operators we work with in Florida, Tennessee, Georgia, and Indiana get the same readiness conversation. The exposure points are predictable. Fix them in this order.
- Medical necessity tied to ASAM Criteria, 4th Edition. Every admission to residential withdrawal management, clinically managed residential, partial hospitalization (an outpatient level of care), and intensive outpatient must trace cleanly to the six dimensions. Carelon reviewers will not give credit for clinical judgment that was not written down.
- Length-of-stay defensibility. Census pressure tempts programs to extend stays. Outlier LOS against peer benchmarks is the fastest way to draw an SIU audit. If your average residential LOS is materially above your state’s Medicaid managed care norm, your utilization management notes need to justify each extension.
- Billing-code intensity. Frequency of H0015, H0010, H0035, group-versus-individual ratios, drug testing units. HHS-OIG found that for 2019 Medicare paid $180 million for drug testing services provided to 274,000 beneficiaries with substance use disorders nationwide, and the improper payment rate was 58.9 percent for the drug test with the highest Medicare fee schedule amount. A follow-on OIG audit tagged 1,062 at-risk providers who billed G0483 for 75% or more of their definitive drug tests, receiving $704.2 million over five years for services flagged as at risk for noncompliance. Definitive drug testing is a known landing zone.
- Internal chart audit cadence. Quarterly, statistically valid sampling. Not vibes. Not AI-only. Human auditors who can read a treatment plan against the bill and tell you whether it holds.
- Compliance committee minutes. When Carelon’s letter arrives, the first thing requested will be your compliance program documentation. If your committee has not met in six months, your leadership team starts from behind.
Other payers will copy this playbook
Elevance is not the only payer doing this; it is the one being explicit about it. UnitedHealth’s Optum, Centene, Molina, and the regional Blues plans all run comparable programs. HHS-OIG has already telegraphed the multi-state sweep on ABA: the same watchdog office has now published audits on Indiana, Wisconsin, Maine, and Colorado in the same series, and STAT reported that the OIG announced in 2022 it would conduct reviews of Medicaid ABA payments in seven states, with Colorado alone showing $285.2 million in improper and potentially improper payments over 2022 and 2023. State Medicaid agencies will lean on plans to close those gaps. Plans will lean on you.
The operators who handle this well will not be the ones with the loudest compliance language on their website. They will be the ones whose clinicians, utilization management staff, and billers have documentation, LOC assignments, and claims that line up so cleanly an analytics outlier flag resolves on first medical-record review. Be boring on the dashboard.
Frequently asked questions
What did Elevance Health actually announce about behavioral health billing analytics?
On the January 28, 2026 Q4 2025 earnings call, CEO Gail Boudreaux told investors Elevance is strengthening analytics to identify outlier utilization and billing patterns in high-cost SUD treatment settings, with follow-through via provider education, claims review enhancements, and payment accuracy and compliance initiatives. The work is being run primarily through Carelon, and Elevance has confirmed that predictive analytics supported by AI is embedded across the organization and is identifying members at risk for concerns including substance use disorder.
How big is the Medicaid documentation problem CMS and payers are looking at?
CMS reported an FY2024 Medicaid improper payment rate of 5.09%, or $31.10 billion, with 79.11% of those improper payments stemming from insufficient documentation. The FY2025 rate rose to 6.12%, or $37.39 billion, with 77.17% still driven by insufficient documentation. That is the lever payers pull first because it requires no fraud finding, just a records gap.
Which behavioral health services are most likely to be flagged first?
Expect early focus on residential SUD treatment, partial hospitalization (which is outpatient under ASAM), intensive outpatient, definitive drug testing, and ABA. HHS-OIG documented a 58.9% improper payment rate for the highest-cost Medicare drug testing code (G0483) on $180 million in 2019 spending across 274,000 SUD beneficiaries, and has issued Medicaid audit reports on Colorado ($77.8M), Maine ($45.6M), Indiana ($56M), and Wisconsin ($18.5M). Carelon’s models will mirror those federal targets.
What should a multi-state behavioral health operator do in the next 90 days?
Run a focused internal audit on medical-necessity documentation tied to ASAM Criteria, 4th Edition; length-of-stay defensibility against payer benchmarks; billing-code intensity for H-codes and drug testing units; and utilization management notes. Convene the compliance committee, document the meeting, and pre-build an audit response playbook so the first Carelon letter does not catch leadership flat-footed. The goal is to be unremarkable on the payer’s outlier dashboard.
References
- Elevance Health (ELV) Q4 2025 Earnings Call Transcript. The Motley Fool (Jan. 28, 2026)
- Healthcare Finance News: Despite Q1 profit decline, Elevance Health raises financial outlook (Apr. 22, 2026)
- CMS: Fiscal Year 2024 Improper Payments Fact Sheet
- CMS: Fiscal Year 2025 Improper Payments Fact Sheet
- Ohio Auditor of State: Press release, Empowered for Excellence Behavioral Health of Ohio compliance examination (Dec. 2, 2025)
- HHS-OIG: Colorado Made at Least $77.8 Million in Improper Fee-for-Service Medicaid Payments for ABA (A-09-24-02004, Feb. 2026)
- HHS-OIG: Opportunities Exist for CMS and Its Medicare Contractors to Strengthen Program Safeguards for Drug Testing Services (A-09-20-03017, Jun. 2021)
- HHS-OIG: Medicare Could Have Saved Up to $216 Million Over 5 Years on At-Risk Definitive Drug Testing Payments (2023)
- STAT: Federal Medicaid audit finds massive overpayment for autism therapy in Colorado (Mar. 2, 2026)